simvastatin has been researched along with Anti-Phospholipid Antibody Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kotyla, PJ | 1 |
| Franzke, CW; Girardi, G; Mackman, N; Redecha, P; Ruf, W | 1 |
| Ferrara, DE; Pierangeli, SS | 1 |
3 other study(ies) available for simvastatin and Anti-Phospholipid Antibody Syndrome
| Article | Year |
|---|---|
Simvastatin reduces antiphospholipid antibodies formation in patients with systemic lupus erythematosus: a preliminary study.
Topics: Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Female; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Simvastatin; Treatment Outcome; Young Adult | 2018 |
Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome.
Topics: Animals; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Disease Models, Animal; Factor VIIa; Female; Fetal Death; Gene Deletion; Gene Expression Regulation; Humans; Immunoglobulin G; Mice; Mice, Inbred C57BL; Mice, Knockout; Neutrophil Activation; Neutrophils; Phagocytosis; Pregnancy; Reactive Oxygen Species; Receptor, PAR-1; Receptor, PAR-2; Respiratory Burst; Signal Transduction; Simvastatin; Thromboplastin | 2008 |
More on: fluvastatin inhibits up-regulation of tissue factor expression by antiphospholipid antibodies on endothelial cells.
Topics: Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Contraindications; Endothelium, Vascular; Fatty Acids, Monounsaturated; Fibrinolytic Agents; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; NF-kappa B; Pyridines; Simvastatin; Thromboplastin; Thrombosis; Up-Regulation | 2005 |